Status:
RECRUITING
Eating Disorders Genetics Initiative 2
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Queensland Institute of Medical Research
Karolinska Institutet
Conditions:
Anorexia Nervosa
Bulimia Nervosa
Eligibility:
All Genders
12-99 years
Brief Summary
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new partici...
Eligibility Criteria
Inclusion
- A lifetime history of anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorders or no history of any disordered eating behavior, based on DSM-5 criteria algorithms
- Age 12-99 years, depending on country. (US enrollment age is 18-99)
Exclusion
- History of subthreshold disordered eating behaviors.
Key Trial Info
Start Date :
October 28 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06594913
Start Date
October 28 2024
End Date
August 1 2027
Last Update
May 31 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599-7160
2
QIMR Berghofer
Brisbane, Queensland, Australia
3
Comenzar de Nuevo
Monterrey, Mexico
4
University of Otago
Christchurch, Canterbury, New Zealand